Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/26472
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNgwe, T.M.M.
dc.contributor.authorRaini, S.K.
dc.contributor.authorFernando, L.
dc.contributor.authorGunawardene, Y.I.N.S.
dc.contributor.authorInoue, S.
dc.contributor.authorTakamatsu, Y.
dc.contributor.authorUrano, T.
dc.contributor.authorMuthugala, R.
dc.contributor.authorHapugoda, M.
dc.contributor.authorMorita, K.
dc.date.accessioned2023-08-02T04:15:56Z
dc.date.available2023-08-02T04:15:56Z
dc.date.issued2023
dc.identifier.citationJournal of Infection and Public Health.2023;16(9):1435-1442.en_US
dc.identifier.issn1876-0341
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/26472
dc.descriptionindexed for MEDLINEen_US
dc.description.abstractBackground: Zika Virus (ZIKV) is a re-emerging, arthropod-borne flavivirus transmitted by Aedes mosquitoes (Ae. aegypti and Ae. albopictus). The coexistence of dengue virus (DENV) and ZIKV concurrently has been associated with a wide array of neurological complications, which may influence the clinical outcomes of infections. Sri Lanka witnessed a severe dengue epidemic in 2017, characterized by extraordinary and severe disease manifestations with considerable morbidity. Therefore, this study assessed the potential occurrence of ZIKV infection during DENV outbreak in Sri Lanka from 2017 to 2019, which could bear substantial implications for public health. Methods: Five hundred ninety-five serum samples were procured from individuals suspected of dengue and admitted to Kandy National Hospital between 2017 and 2018 and the Negombo District General Hospital between 2018 and 2019. These samples underwent quantitative real-time RT-PCR (qRT-PCR) to identify the presence of the ZIKV gene, while enzyme-linked immunosorbent assay was employed to detect ZIKV-specific IgM and IgG antibodies. Focus reduction neutralization tests were subsequently conducted to confirm ZIKV infection. Results: Among the 595 serum samples, 6 (1.0%) tested positive for ZIKV using qRT-PCR. Anti-ZIKV IgM and IgG were identified in 18.0% and 38.6% patients. Sixty-six (11.0%) samples demonstrated the presence of anti-ZIKV IgM and IgG. Within ZIKV IgM-positive samples, 2.2% exhibited neutralizing antibodies against ZIKV. Through the implementation of qRT-PCR, ZIKV IgM detection, and neutralization testing, 2% and 3.7% cases of ZIKV infections were confirmed in the Kandy and Negombo regions, respectively. Conclusion: This study is the inaugural endeavor to substantiate the existence of ZIKV infection in Sri Lanka utilizing molecular and serological analysis. The findings of this investigation imply that ZIKV was circulating throughout the 2017-2019 DENV outbreak. These results underscore the necessity for improved preparedness for future outbreaks, fortifying governmental policies on public health, and establishing effective early warning systems regarding the emergence of these virusesen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectAcute Zika virus infectionen_US
dc.subjectDengue suspecteden_US
dc.subjectMolecular and serological detectionen_US
dc.subjectPatientsen_US
dc.subjectSri Lankaen_US
dc.titleEpidemiological evidence of acute transmission of zika virus infection in dengue suspected patients in Sri-Lankaen_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
1-s2.0-S1876034123002484-main.pdf2.83 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.